NIH-funded research NIH-funded research

Investigating how a yeast can deliver therapeutic proteins in the gut of mice

Official title: Characterization of colonization and protein secretion by Pichia pastoris in the gastrointestinal tract of mice

Funded at University of the Pacific-Stockton · NIH-10937834 · Data updated 2026-11-12

This study is looking at how a special yeast can safely deliver helpful proteins directly in the stomachs of mice, which could lead to new ways to treat certain health conditions in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of the Pacific-Stockton
NIH-funded
Lab location1 site (Stockton, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2028
Funding year2024
Award (this year)$165,250
NIH project number1R16GM157998-01
Project IDNIH-10937834 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for potential benefits from this research would be adults with conditions that could be treated with therapeutic proteins.

Less likely to help

Patients with gastrointestinal disorders or those who cannot tolerate yeast-based therapies may not benefit from this research.

What this research studies

This research explores the use of the yeast Pichia pastoris as a delivery system for therapeutic proteins directly in the gastrointestinal tract of mice. By allowing the yeast to produce and secrete proteins in situ, the study aims to overcome challenges related to protein stability and delivery. The researchers have previously shown that this yeast can survive in the gut and secrete beneficial proteins without causing inflammation. The goal is to understand how effectively this method can be used for future therapeutic applications.

Why it matters

Potential benefit: If successful, this research could lead to more effective and stable delivery methods for therapeutic proteins, improving treatment options for various diseases.

How similar studies have gone: While the use of yeast for protein delivery is a novel approach, preliminary studies have shown promising results in similar applications.

Where this research is happening

  • University of the Pacific-Stockton
    Stockton, United States
    Active

Researchers

  • Principal investigator: Thor, Der — University of the Pacific-Stockton
  • Study coordinator: Thor, Der

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.